##GS140549_01 ref_correl: 0.962 (median: 0.971)
##GS140549_01 cnvs: 167 (median: 43)
##GS140549_01 qc_errors: 
#chr	start	end	sample	size	region_count	region_copy_numbers	region_zscores	region_cnv_af	region_coordinates	overlaps_cnp_region	genes	dosage_sensitive_disease_genes	omim
chr1	5923940	5924103	GS140549_01	164	1	3	4.14	0.033	chr1:5923940-5924103		NPHP4		607215_[NPHP4_(PROVISIONAL)_NEPHRONOPHTHISIS_4,606966|SENIOR-LOKEN_SYNDROME_4,606996]
chr1	6534501	6534657	GS140549_01	157	1	3	4.16	0.052	chr1:6534501-6534657		PLEKHG5		611101_[PLEKHG5_(CONFIRMED)_SPINAL_MUSCULAR_ATROPHY,DISTAL,AUTOSOMAL_RECESSIVE,4,611067|CHARCOT-MARIE-TOOTH_DISEASE,RECESSIVE_INTERMEDIATE_C,615376]
chr1	10434902	10435114	GS140549_01	213	1	3	3.62	0.007	chr1:10434902-10435114		KIF1B		605995_[KIF1B_(CONFIRMED)_CHARCOT-MARIE-TOOTH_DISEASE,TYPE_2A1,118210|PHEOCHROMOCYTOMA,171300|NEUROBLASTOMA,SUSCEPTIBILITY_TO,1,256700]
chr1	17326496	17327039	GS140549_01	544	2	3,3	2.60,4.53	0.065,0.059	chr1:17326496-17326647,chr1:17326885-17327039		ATP13A2		610513_[ATP13A2_(CONFIRMED)_KUFOR-RAKEB_SYNDROME,606693|SPASTIC_PARAPLEGIA_78,AUTOSOMAL_RECESSIVE,617225]
chr1	22154513	22154655	GS140549_01	143	1	1	-3.57	0.020	chr1:22154513-22154655		HSPG2	HSPG2	142461_[HSPG2_(CONFIRMED)_SCHWARTZ-JAMPEL_SYNDROME,TYPE_1,255800|DYSSEGMENTAL_DYSPLASIA,SILVERMAN-HANDMAKER_TYPE,224410]
chr1	22204669	22204756	GS140549_01	88	1	3	4.33	0.039	chr1:22204669-22204756		HSPG2	HSPG2	142461_[HSPG2_(CONFIRMED)_SCHWARTZ-JAMPEL_SYNDROME,TYPE_1,255800|DYSSEGMENTAL_DYSPLASIA,SILVERMAN-HANDMAKER_TYPE,224410]
chr1	26136164	26136321	GS140549_01	158	1	3	3.85	0.065	chr1:26136164-26136321		SELENON		606210_[SEPN1_(CONFIRMED)_MUSCULAR_DYSTROPHY,RIGID_SPINE,1,602771|MYOPATHY,CONGENITAL,WITH_FIBER-TYPE_DISPROPORTION,255310]
chr1	27057633	27058105	GS140549_01	473	1	3	3.57	0.020	chr1:27057633-27058105		ARID1A	ARID1A	603024_[ARID1A_(PROVISIONAL)_COFFIN-SIRIS_SYNDROME_2,614607]
chr1	44201894	44202106	GS140549_01	213	1	3	3.87	0.013	chr1:44201894-44202106		ST3GAL3		606494_[ST3GAL3_(PROVISIONAL)_MENTAL_RETARDATION,AUTOSOMAL_RECESSIVE_12,611090|EPILEPTIC_ENCEPHALOPATHY,EARLY_INFANTILE,15,615006]
chr1	76199203	76199323	GS140549_01	121	1	3	3.76	0.033	chr1:76199203-76199323		ACADM		607008_[ACADM_(PROVISIONAL)_ACYL-COA_DEHYDROGENASE,MEDIUM_CHAIN,DEFICIENCY_OF,201450]
chr1	155791255	155792277	GS140549_01	1023	2	3,3	2.02,3.50	0.039,0.026	chr1:155791255-155791349,chr1:155792067-155792277		GON4L		
chr1	198671506	198671669	GS140549_01	164	1	3	4.50	0.039	chr1:198671506-198671669		PTPRC		151460_[PTPRC_(CONFIRMED)_HEPATITIC_C_VIRUS,SUSCEPTIBILITY_TO,609532|SEVERE_COMBINED_IMMUNODEFICIENCY,T_CELL-NEGATIVE,B-CELL/NATURAL_KILLER-CELL_POSITIVE,608971]
chr1	215931927	215932104	GS140549_01	178	1	3	4.02	0.020	chr1:215931927-215932104		USH2A		608400_[USH2A_(CONFIRMED)_USHER_SYNDROME,TYPE_2A,276901|RETINITIS_PIGMENTOSA_39,613809]
chr1	235914500	235914672	GS140549_01	173	1	3	5.15	0.065	chr1:235914500-235914672		LYST		606897_[LYST_(CONFIRMED)_CHEDIAK-HIGASHI_SYNDROME,214500]
chr2	73635740	73635885	GS140549_01	146	1	3	3.82	0.033	chr2:73635740-73635885		ALMS1		606844_[ALMS1_(CONFIRMED)_ALSTROM_SYNDROME,203800]
chr2	73653571	73653691	GS140549_01	121	1	3	3.79	0.026	chr2:73653571-73653691		ALMS1		606844_[ALMS1_(CONFIRMED)_ALSTROM_SYNDROME,203800]
chr2	86088294	86088425	GS140549_01	132	1	3	3.85	0.013	chr2:86088294-86088425		ST3GAL5		604402_[ST3GAL5_(CONFIRMED)_SALT_AND_PEPPER_DEVELOPMENTAL_REGRESSION_SYNDROME,609056]
chr2	106468194	106468363	GS140549_01	170	1	3	6.60	0.065	chr2:106468194-106468363		NCK2	NCK2	
chr2	127815039	127816741	GS140549_01	1703	2	3,3	3.52,2.88	0.059,0.092	chr2:127815039-127815187,chr2:127816577-127816741		BIN1		601248_[BIN1_(PROVISIONAL)_MYOPATHY,CENTRONUCLEAR,AUTOSOMAL_RECESSIVE,255200]
chr2	152446393	152447979	GS140549_01	1587	2	3,3	3.15,5.92	0.078,0.092	chr2:152446393-152446724,chr2:152447852-152447979		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	152459091	152461395	GS140549_01	2305	3	3,3,3	2.36,5.78,2.52	0.059,0.085,0.046	chr2:152459091-152459215,chr2:152460073-152460296,chr2:152461064-152461395		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	152482038	152484358	GS140549_01	2321	3	3,3,3	3.52,3.70,4.38	0.085,0.098,0.072	chr2:152482038-152482162,chr2:152483506-152483729,chr2:152484027-152484358		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	152496859	152497190	GS140549_01	332	1	3	4.60	0.072	chr2:152496859-152497190		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	152500322	152500653	GS140549_01	332	1	3	4.85	0.065	chr2:152500322-152500653		NEB		161650_[NEB_(CONFIRMED)_NEMALINE_MYOPATHY_2,AUTOSOMAL_RECESSIVE,256030]
chr2	170127404	170127627	GS140549_01	224	1	3	4.04	0.065	chr2:170127404-170127627		LRP2	LRP2	600073_[LRP2_(CONFIRMED)_DONNAI-BARROW_SYNDROME,222448]
chr2	175622664	175622758	GS140549_01	95	1	3	3.58	0.020	chr2:175622664-175622758		CHRNA1		100690_[CHRNA1_(CONFIRMED)_MYASTHENIC_SYNDROME,CONGENITAL,1A,SLOW-CHANNEL,601462|MYASTHENIC_SYNDROME,CONGENITAL,1B,FAST-CHANNEL,608930|MULTIPLE_PTERYGIUM_SYNDROME,LETHAL_TYPE,253290]
chr2	178310264	178310364	GS140549_01	101	1	1	-3.53	0.013	chr2:178310264-178310364		AGPS		603051_[AGPS_(PROVISIONAL)_RHIZOMELIC_CHONDRODYSPLASIA_PUNCTATA,TYPE_3,600121]
chr2	202608971	202609162	GS140549_01	192	1	3	4.17	0.052	chr2:202608971-202609162		ALS2		606352_[ALS2_(CONFIRMED)_AMYOTROPHIC_LATERAL_SCLEROSIS_2,JUVENILE,205100|PRIMARY_LATERAL_SCLEROSIS,JUVENILE,606353|SPASTIC_PARALYSIS,INFANTILE_ONSET_ASCENDING,607225]
chr2	202631942	202632116	GS140549_01	175	1	3	3.63	0.020	chr2:202631942-202632116		ALS2		606352_[ALS2_(CONFIRMED)_AMYOTROPHIC_LATERAL_SCLEROSIS_2,JUVENILE,205100|PRIMARY_LATERAL_SCLEROSIS,JUVENILE,606353|SPASTIC_PARALYSIS,INFANTILE_ONSET_ASCENDING,607225]
chr2	215822991	215823188	GS140549_01	198	1	3	3.72	0.046	chr2:215822991-215823188		ABCA12		607800_[ABCA12_(CONFIRMED)_ICHTHYOSIS,CONGENITAL,AUTOSOMAL_RECESSIVE_4A,601277|ICHTHYOSIS,CONGENITAL,AUTOSOMAL_RECESSIVE_4B_(HARLEQUIN),242500]
chr2	233394639	233394859	GS140549_01	221	1	3	4.05	0.072	chr2:233394639-233394859		CHRND		100720_[CHRND_(CONFIRMED)_MYASTHENIC_SYNDROME,CONGENITAL,3A,SLOW-CHANNEL,616321|MYASTHENIC_SYNDROME,CONGENITAL,3B,FAST-CHANNEL,616322|MYASTHENIC_SYNDROME,CONGENITAL,3C,ASSOCIATED_WITH_ACETYLCHOLINE_RECEPTOR_DEFICIENCY,616323|MULTIPLE_PTERYGIUM_SYNDROME,LETHAL_TYPE,253290]
chr2	233407582	233407802	GS140549_01	221	1	3	4.37	0.046	chr2:233407582-233407802		CHRNG		100730_[CHRNG_(CONFIRMED)_ESCOBAR_SYNDROME,265000|MULTIPLE_PTERYGIUM_SYNDROME,LETHAL_TYPE,253290]
chr3	4829621	4829833	GS140549_01	213	1	3	4.09	0.026	chr3:4829621-4829833		ITPR1	ITPR1	147265_[ITPR1_(CONFIRMED)_SPINOCEREBELLAR_ATAXIA_15,606658|SPINOCEREBELLAR_ATAXIA_29,CONGENITAL_NONPROGRESSIVE,117360|GILLESPIE_SYNDROME,206700]
chr3	8775476	8775686	GS140549_01	211	1	3	3.87	0.052	chr3:8775476-8775686		CAV3		601253_[CAV3_(CONFIRMED)_MUSCULAR_DYSTROPHY,LIMB-GIRDLE,TYPE_IC,607801|RIPPLING_MUSCLE_DISEASE,606072|CREATINE_PHOSPHOKINASE,ELEVATED_SERUM,123320|MYOPATHY,DISTAL,TATEYAMA_TYPE,614321|CARDIOMYOPATHY,FAMILIAL_HYPERTROPHIC,192600|LONG_QT_SYNDROME_9,611818]
chr3	10119755	10119891	GS140549_01	137	1	3	4.46	0.020	chr3:10119755-10119891		FANCD2		613984_[FANCD2_(PROVISIONAL)_FANCONI_ANEMIA,COMPLEMENTATION_GROUP_D2,227646]
chr3	48607557	48607777	GS140549_01	221	2	3,3	3.64,2.75	0.039,0.039	chr3:48607557-48607621,chr3:48607698-48607777		COL7A1		120120_[COL7A1_(CONFIRMED)_EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AD,131750|EPIDERMOLYSIS_BULLOSA_DYSTROPHICA,AR,226600|EPIDERMOLYSIS_BULLOSA,PRETIBIAL,131850|EBD,BART_TYPE,132000|EBD,LOCALISATA_VARIANT|TRANSIENT_BULLOUS_OF_THE_NEWBORN,131705|EPIDERMOLYSIS_BULLOSA_PRURIGINOSA,604129|TOENAIL_DYSTROPHY,ISOLATED,607523|EBD_INVERSA,226600]
chr3	142185156	142185385	GS140549_01	230	1	3	4.38	0.046	chr3:142185156-142185385		ATR	ATR	601215_[ATR_(CONFIRMED)_SECKEL_SYNDROME_1,210600|CUTANEOUS_TELANGIECTASIA_AND_CANCER_SYNDROME,FAMILIAL,614564]
chr3	184075140	184075285	GS140549_01	146	1	1	-3.95	0.046	chr3:184075140-184075285		CLCN2,EIF2B5	CLCN2	600570_[CLCN2_(CONFIRMED)_EPILEPSY,JUVENILE_MYOCLONIC,SUSCEPTIBILITY_TO,8,607628|EPILEPSY,JUVENILE_ABSENCE,SUSCEPTIBILITY_TO,2,607628|EPILEPSY,IDIOPATHIC_GENERALIZED,SUSCEPTIBILITY_TO,11,607628|LEUKOENCEPHALOPATHY_WITH_ATAXIA,615651]
chr3	196792569	196792690	GS140549_01	122	1	3	3.72	0.033	chr3:196792569-196792690		DLG1	DLG1	
chr3	196846271	196857552	GS140549_01	11282	2	3,3	3.91,3.09	0.013,0.033	chr3:196846271-196846411,chr3:196857388-196857552		DLG1	DLG1	
chr4	1986525	1986656	GS140549_01	132	1	3	4.13	0.072	chr4:1986525-1986656		NELFA	NELFA	
chr5	1432569	1432823	GS140549_01	255	1	3	6.25	0.078	chr5:1432569-1432823		SLC6A3		126455_[SLC6A3_(CONFIRMED)_NICOTINE_DEPENDENCE,PROTECTION_AGAINST,188890|PARKINSONISM-DYSTONIA,INFANTILE,613135]
chr5	7873476	7873649	GS140549_01	174	1	3	3.67	0.033	chr5:7873476-7873649		MTRR		602568_[MTRR_(PROVISIONAL)_HOMOCYSTINURIA-MEGALOBLASTIC_ANEMIA,CBL_E_TYPE,236270|NEURAL_TUBE_DEFECTS,FOLATE-SENSITIVE,SUSCEPTIBILITY_TO,601634]
chr5	88183309	88183425	GS140549_01	117	1	3	3.52	0.039	chr5:88183309-88183425		MEF2C,MEF2C-AS1	MEF2C	600662_[MEF2C_(CONFIRMED)_MENTAL_RETARDATION,STEREOTYPIC_MOVEMENTS,EPILEPSY,AND/OR_CEREBRAL_MALFORMATIONS,613443|CHROMOSOME_5Q14.3_DELETION_SYNDROME,613443]
chr5	90072260	90072403	GS140549_01	144	1	3	4.03	0.072	chr5:90072260-90072403		ADGRV1	ADGRV1	602851_[GPR98_(CONFIRMED)_FEBRILE_SEIZURES,FAMILIAL,4,604352|USHER_SYNDROME,TYPE_2C,605472|USHER_SYNDROME,TYPE_2C,GPR98/PDZD7_DIGENIC,605472]
chr5	127599107	127599358	GS140549_01	252	1	3	4.89	0.085	chr5:127599107-127599358		FBN2		612570_[FBN2_(PROVISIONAL)_CONTRACTURAL_ARACHNODACTYLY,CONGENITAL,121050|MACULAR_DEGENERATION,EARLY-ONSET,616118]
chr5	127648316	127653973	GS140549_01	5658	2	3,3	5.22,3.18	0.039,0.026	chr5:127648316-127648497,chr5:127653831-127653973		FBN2		612570_[FBN2_(PROVISIONAL)_CONTRACTURAL_ARACHNODACTYLY,CONGENITAL,121050|MACULAR_DEGENERATION,EARLY-ONSET,616118]
chr5	176715810	176715936	GS140549_01	127	1	3	3.54	0.026	chr5:176715810-176715936		NSD1	NSD1	606681_[NSD1_(CONFIRMED)_SOTOS_SYNDROME_1,117550|LEUKEMIA,ACUTE_MYELOID,601626|BECKWITH-WIEDEMANN_SYNDROME,130650]
chr6	31963486	31963581	GS140549_01	96	1	4	5.14	0.072	chr6:31963486-31963581	yes	C4A	C4A	120810_[C4A_(CONFIRMED)_C4A_DEFICIENCY,614380|BLOOD_GROUP,RODGERS,614374]
chr6	101247297	101247458	GS140549_01	162	1	3	4.21	0.059	chr6:101247297-101247458		ASCC3		
chr6	129761951	129762153	GS140549_01	203	1	3	3.61	0.033	chr6:129761951-129762153		LAMA2		156225_[LAMA2_(CONFIRMED)_MUSCULAR_DYSTROPHY,CONGENITAL_MEROSIN-DEFICIENT,607855|MUSCULAR_DYSTROPHY,CONGENITAL,DUE_TO_PARTIAL_LAMA2_DEFICIENCY,607855]
chr6	152577759	152577910	GS140549_01	152	1	3	3.61	0.007	chr6:152577759-152577910		SYNE1		608441_[SYNE1_(CONFIRMED)_SPINOCEREBELLAR_ATAXIA,AUTOSOMAL_RECESSIVE_8,610743|EMERY-DREIFUSS_MUSCULAR_DYSTROPHY_4,AUTOSOMAL_DOMINANT,612998]
chr6	152777011	152777189	GS140549_01	179	1	3	3.63	0.007	chr6:152777011-152777189		SYNE1		608441_[SYNE1_(CONFIRMED)_SPINOCEREBELLAR_ATAXIA,AUTOSOMAL_RECESSIVE_8,610743|EMERY-DREIFUSS_MUSCULAR_DYSTROPHY_4,AUTOSOMAL_DOMINANT,612998]
chr7	42065788	42079848	GS140549_01	14061	2	3,3	4.45,2.83	0.085,0.026	chr7:42065788-42066021,chr7:42079627-42079848		GLI3	GLI3	165240_[GLI3_(CONFIRMED)_GREIG_CEPHALOPOLYSYNDACTYLY_SYNDROME,175700|PALLISTER-HALL_SYNDROME,146510|POLYDACTYLY,PREAXIAL,TYPE_IV,174700|POLYDACTYLY,POSTAXIAL,TYPES_A1_AND_B,174200|HYPOTHALAMIC_HAMARTOMAS,SOMATIC,241800]
chr7	65547857	65548171	GS140549_01	315	2	1,1	-3.98,-2.64	0.039,0.026	chr7:65547857-65547933,chr7:65548054-65548171		ASL		608310_[ASL_(CONFIRMED)_ARGININOSUCCINIC_ACIDURIA,207900]
chr7	73474696	73474841	GS140549_01	146	1	3	3.84	0.078	chr7:73474696-73474841		ELN	ELN	130160_[ELN_(CONFIRMED)_SUPRAVALVAR_AORTIC_STENOSIS,185500|CUTIS_LAXA,AUTOSOMAL_DOMINANT,123700],608512_[NCF1_(PROVISIONAL)_CHRONIC_GRANULOMATOUS_DISEASE_DUE_TO_DEFICIENCY_OF_NCF-1,233700]
chr7	74160666	74160760	GS140549_01	95	1	1	-3.84	0.092	chr7:74160666-74160760		GTF2I,STAG3L2	GTF2I	608512_[NCF1_(PROVISIONAL)_CHRONIC_GRANULOMATOUS_DISEASE_DUE_TO_DEFICIENCY_OF_NCF-1,233700]
chr7	74195116	74195191	GS140549_01	76	1	1	-5.74	0.072	chr7:74195116-74195191		NCF1,STAG3L2	NCF1	608512_[NCF1_(PROVISIONAL)_CHRONIC_GRANULOMATOUS_DISEASE_DUE_TO_DEFICIENCY_OF_NCF-1,233700]
chr7	75933291	75933624	GS140549_01	334	1	3	4.12	0.013	chr7:75933291-75933624		HSPB1		602195_[HSPB1_(CONFIRMED)_NEUROPATHY,DISTAL_HEREDITARY_MOTOR,TYPE_IIB,608634|CHARCOT-MARIE-TOOTH_DISEASE,AXONAL,TYPE_2F,606595]
chr7	114268585	114268742	GS140549_01	158	1	3	4.02	0.085	chr7:114268585-114268742		FOXP2	FOXP2	605317_[FOXP2_(CONFIRMED)_SPEECH-LANGUAGE_DISORDER-1,602081]
chr7	114293971	114298332	GS140549_01	4362	2	3,4	2.22,5.58	0.039,0.105	chr7:114293971-114294208,chr7:114298111-114298332		FOXP2	FOXP2	605317_[FOXP2_(CONFIRMED)_SPEECH-LANGUAGE_DISORDER-1,602081]
chr7	128494018	128494280	GS140549_01	263	1	1	-4.48	0.026	chr7:128494018-128494280	yes	FLNC		102565_[FLNC_(CONFIRMED)_MYOPATHY,MYOFIBRILLAR,5,609524|MYOPATHY,DISTAL,4,614065|CARDIOMYOPATHY,FAMILIAL_HYPERTROPHIC,26|CARDIOMYOPATHY,FAMILIAL_RESTRICTIVE_5,617047]
chr7	139829283	139829463	GS140549_01	181	1	3	4.21	0.039	chr7:139829283-139829463		KDM7A		
chr7	142997463	142997543	GS140549_01	81	1	1	-3.91	0.065	chr7:142997463-142997543		CASP2		
chr7	143043223	143043354	GS140549_01	132	1	3	4.33	0.046	chr7:143043223-143043354		CLCN1	CLCN1	118425_[CLCN1_(PROVISIONAL)_MYOTONIA_CONGENITA,RECESSIVE,255700|MYOTONIA_CONGENITA,DOMINANT,160800|MYOTONIA_LEVIOR,RECESSIVE]
chr7	147914370	147914626	GS140549_01	257	1	3	3.91	0.039	chr7:147914370-147914626		CNTNAP2	CNTNAP2	604569_[CNTNAP2_(CONFIRMED)_CORTICAL_DYSPLASIA-FOCAL_EPILEPSY_SYNDROME,610042|AUTISM_SUSCEPTIBILITY_15,612100|PITT-HOPKINS_LIKE_SYNDROME_1,610042]
chr8	1857451	1857646	GS140549_01	196	1	1	-3.80	0.033	chr8:1857451-1857646		ARHGEF10		608136_[ARHGEF10_(CONFIRMED)_SLOWED_NERVE_CONDUCTION_VELOCITY,AD,608236]
chr8	22020077	22020255	GS140549_01	179	1	3	6.58	0.085	chr8:22020077-22020255		SFTPC		178620_[SFTPC_(CONFIRMED)_SURFACTANT_METABOLISM_DYSFUNCTION,PULMONARY,2,610913]
chr8	48746747	48746967	GS140549_01	221	1	3	4.49	0.033	chr8:48746747-48746967		PRKDC		600899_[PRKDC_(CONFIRMED)_IMMUNODEFICIENCY_26,WITH_OR_WITHOUT_NEUROLOGIC_ABNORMALITIES,615966]
chr8	126069788	126069918	GS140549_01	131	1	3	5.63	0.039	chr8:126069788-126069918		WASHC5		610657_[KIAA0196_(CONFIRMED)_SPASTIC_PARAPLEGIA_8,AUTOSOMAL_DOMINANT,603563|RITSCHER-SCHINZEL_SYNDROME_1,220210]
chr8	126090970	126094013	GS140549_01	3044	2	3,3	3.59,2.78	0.039,0.007	chr8:126090970-126091182,chr8:126093893-126094013		WASHC5		610657_[KIAA0196_(CONFIRMED)_SPASTIC_PARAPLEGIA_8,AUTOSOMAL_DOMINANT,603563|RITSCHER-SCHINZEL_SYNDROME_1,220210]
chr8	134108440	134108627	GS140549_01	188	1	3	3.81	0.013	chr8:134108440-134108627		SLA,TG		188450_[TG_(CONFIRMED)_THYROID_DYSHORMONOGENESIS_3,274700|AUTOIMMUNE_THYROID_DISEASE,SUSCEPTIBILITY_TO,3,608175]
chr9	732368	732627	GS140549_01	260	1	3	4.34	0.039	chr9:732368-732627		KANK1	KANK1	607704_[KANK1_(CONFIRMED)_CEREBRAL_PALSY,SPASTIC_QUADRIPLEGIC,2,612900]
chr9	2635443	2635582	GS140549_01	140	1	3	3.88	0.039	chr9:2635443-2635582		VLDLR		192977_[VLDLR_(CONFIRMED)_CEREBELLAR_HYPOPLASIA_AND_MENTAL_RETARDATION_WITH_OR_WITHOUT_QUADRUPEDAL_LOCOMOTION_1,224050]
chr9	98238306	98238451	GS140549_01	146	1	1	-4.56	0.026	chr9:98238306-98238451		PTCH1	PTCH1	601309_[PTCH1_(CONFIRMED)_BASAL_CELL_NEVUS_SYNDROME,109400|BASAL_CELL_CARCINOMA,SOMATIC,605462|HOLOPROSENCEPHALY_7,610828]
chr9	98241272	98242382	GS140549_01	1111	2	3,3	3.56,2.72	0.065,0.052	chr9:98241272-98241439,chr9:98242241-98242382		PTCH1	PTCH1	601309_[PTCH1_(CONFIRMED)_BASAL_CELL_NEVUS_SYNDROME,109400|BASAL_CELL_CARCINOMA,SOMATIC,605462|HOLOPROSENCEPHALY_7,610828]
chr9	135206654	135211912	GS140549_01	5259	3	3,3,3	4.94,3.10,2.24	0.065,0.020,0.052	chr9:135206654-135206845,chr9:135209985-135210124,chr9:135211673-135211912		SETX		608465_[SETX_(CONFIRMED)_AMYOTROPHIC_LATERAL_SCLEROSIS_4,JUVENILE,602433|SPINOCEREBELLAR_ATAXIA,AUTOSOMAL_RECESSIVE_1,606002]
chr9	135798725	135801136	GS140549_01	2412	2	3,3	3.64,2.81	0.020,0.020	chr9:135798725-135798889,chr9:135800964-135801136		TSC1	TSC1	605284_[TSC1_(CONFIRMED)_TUBEROUS_SCLEROSIS-1,191100|LYMPHANGIOLEIOMYOMATOSIS,606690|FOCAL_CORTICAL_DYSPLASIA,TYPE_II,SOMATIC,607341]
chr9	136412150	136412345	GS140549_01	196	1	3	3.51	0.033	chr9:136412150-136412345		ADAMTSL2		612277_[ADAMTSL2_(PROVISIONAL)_GELEOPHYSIC_DYSPLASIA_1,231050]
chr9	139325444	139325579	GS140549_01	136	1	3	3.75	0.059	chr9:139325444-139325579		INPP5E		613037_[INPP5E_(PROVISIONAL)_MENTAL_RETARDATION,TRUNCAL_OBESITY,RETINAL_DYSTROPHY,AND_MICROPENIS,610156|JOUBERT_SYNDROME_1,213300]
chr10	38299568	38306324	GS140549_01	6757	4	1,1,1,1	-3.45,-4.09,-4.97,-4.04	0.065,0.020,0.033,0.013	chr10:38299568-38299721,chr10:38301216-38301288,chr10:38305789-38305953,chr10:38306209-38306324		ZNF33A		
chr10	50691382	50691572	GS140549_01	191	1	3	3.82	0.026	chr10:50691382-50691572		ERCC6		609413_[ERCC6_(CONFIRMED)_COCKAYNE_SYNDROME,TYPE_B,133540|CEREBROOCULOFACIOSKELETAL_SYNDROME_1,214150|DE_SANCTIS-CACCHIONE_SYNDROME,278800|MACULAR_DEGENERATION,AGE-RELATED,SUSCEPTIBILITY_TO,5,613761|UV-SENSITIVE_SYNDROME_1,600630|LUNG_CANCER,SUSCEPTIBILITY_TO,211980|PREMATURE_OVARIAN_FAILURE_11,616946]
chr10	50736453	50736581	GS140549_01	129	1	3	3.50	0.020	chr10:50736453-50736581		ERCC6,PGBD3		609413_[ERCC6_(CONFIRMED)_COCKAYNE_SYNDROME,TYPE_B,133540|CEREBROOCULOFACIOSKELETAL_SYNDROME_1,214150|DE_SANCTIS-CACCHIONE_SYNDROME,278800|MACULAR_DEGENERATION,AGE-RELATED,SUSCEPTIBILITY_TO,5,613761|UV-SENSITIVE_SYNDROME_1,600630|LUNG_CANCER,SUSCEPTIBILITY_TO,211980|PREMATURE_OVARIAN_FAILURE_11,616946]
chr10	64578291	64578417	GS140549_01	127	1	1	-3.57	0.059	chr10:64578291-64578417		EGR2		129010_[EGR2_(PROVISIONAL)_NEUROPATHY,CONGENITAL_HYPOMYELINATING,1,605253|CHARCOT-MARIE-TOOTH_DISEASE,TYPE_1D,607678|DEJERINE-SOTTAS_DISEASE,145900]
chr10	73269829	73269991	GS140549_01	163	1	3	3.59	0.026	chr10:73269829-73269991		CDH23,CDH23-AS1		605516_[CDH23_(CONFIRMED)_USHER_SYNDROME,TYPE_1D,601067|DEAFNESS,AUTOSOMAL_RECESSIVE_12,601386|USHER_SYNDROME,TYPE_1D/F_DIGENIC,601067]
chr11	1780736	1780879	GS140549_01	144	1	3	4.25	0.118	chr11:1780736-1780879		CTSD		116840_[CTSD_(CONFIRMED)_CEROID_LIPOFUSCINOSIS,NEURONAL,10,610127]
chr11	22261105	22261240	GS140549_01	136	1	3	4.21	0.065	chr11:22261105-22261240		ANO5		608662_[ANO5_(CONFIRMED)_GNATHODIAPHYSEAL_DYSPLASIA,166260|MUSCULAR_DYSTROPHY,LIMB-GIRDLE,TYPE_2L,611307|MIYOSHI_MUSCULAR_DYSTROPHY_3,613319]
chr11	65638618	65638844	GS140549_01	227	1	3	6.09	0.105	chr11:65638618-65638844		EFEMP2		604633_[EFEMP2_(PROVISIONAL)_CUTIS_LAXA,AUTOSOMAL_RECESSIVE,TYPE_IB,614437]
chr11	68125108	68125325	GS140549_01	218	1	3	3.90	0.046	chr11:68125108-68125325		LRP5		603506_[LRP5_(CONFIRMED)_OSTEOPOROSIS-PSEUDOGLIOMA_SYNDROME,259770|BONE_MINERAL_DENSITY_VARIABILITY_1,601884|HYPEROSTOSIS,ENDOSTEAL,144750|VAN_BUCHEM_DISEASE,TYPE_2,607636|OSTEOSCLEROSIS,144750|OSTEOPOROSIS,166710|EXUDATIVE_VITREORETINOPATHY_4,601813|OSTEOPETROSIS,AUTOSOMAL_DOMINANT_1,607634]
chr11	70338430	70338580	GS140549_01	151	1	3	4.57	0.092	chr11:70338430-70338580		SHANK2	SHANK2	603290_[SHANK2_(PROVISIONAL)_AUTISM_SUSCEPTIBILITY_17,613436]
chr11	108009615	108010952	GS140549_01	1338	2	3,3	2.71,4.09	0.026,0.026	chr11:108009615-108009778,chr11:108010782-108010952		ACAT1		607809_[ACAT1_(CONFIRMED)_ALPHA-METHYLACETOACETIC_ACIDURIA,203750]
chr12	939159	939336	GS140549_01	178	1	3	3.81	0.007	chr12:939159-939336		WNK1		605232_[WNK1_(CONFIRMED)_PSEUDOHYPOALDOSTERONISM,TYPE_IIC,614492|NEUROPATHY,HEREDITARY_SENSORY_AND_AUTONOMIC,TYPE_II,201300]
chr12	5019063	5019648	GS140549_01	586	1	3	3.71	0.020	chr12:5019063-5019648		KCNA1	KCNA1	176260_[KCNA1_(CONFIRMED)_EPISODIC_ATAXIA/MYOKYMIA_SYNDROME,160120]
chr12	7361591	7361776	GS140549_01	186	1	3	3.82	0.052	chr12:7361591-7361776		PEX5		600414_[PEX5_(CONFIRMED)_PEROXISOME_BIOGENESIS_DISORDER_2A_(ZELLWEGER),214110|PEROXISOME_BIOGENESIS_DISORDER_2B,202370|RHIZOMELIC_CHONDRODYSPLASIA_PUNCTATA,TYPE_5,616716]
chr12	13768038	13768211	GS140549_01	174	1	3	4.63	0.052	chr12:13768038-13768211		GRIN2B	GRIN2B	138252_[GRIN2B_(PROVISIONAL)_MENTAL_RETARDATION,AUTOSOMAL_DOMINANT_6,613970|EPILEPTIC_ENCEPHALOPATHY,EARLY_INFANTILE,27,616139]
chr12	41331362	41331499	GS140549_01	138	1	3	4.26	0.072	chr12:41331362-41331499		CNTN1		600016_[CNTN1_(PROVISIONAL)_MYOPATHY,CONGENITAL,COMPTON-NORTH,612540]
chr12	51080346	51080475	GS140549_01	130	1	3	3.74	0.039	chr12:51080346-51080475		DIP2B		611379_[DIP2B_(PROVISIONAL)_MENTAL_RETARDATION,FRA12A_TYPE,136630]
chr12	56090990	56091071	GS140549_01	82	1	1	-4.02	0.039	chr12:56090990-56091071		ITGA7		600536_[ITGA7_(PROVISIONAL)_MUSCULAR_DYSTROPHY,CONGENITAL,DUE_TO_ITGA7_DEFICIENCY,613204]
chr12	57966353	57966519	GS140549_01	167	1	3	3.52	0.039	chr12:57966353-57966519		KIF5A		602821_[KIF5A_(CONFIRMED)_SPASTIC_PARAPLEGIA_10,AUTOSOMAL_DOMINANT,604187|MYOCLONUS,INTRACTABLE,NEONATAL,617235]
chr12	66932848	66933013	GS140549_01	166	1	3	3.52	0.039	chr12:66932848-66933013		GRIP1	GRIP1	604597_[GRIP1_(PROVISIONAL)_FRASER_SYNDROME,219000]
chr12	102155332	102155551	GS140549_01	220	1	3	4.11	0.013	chr12:102155332-102155551		GNPTAB		607840_[GNPTAB_(CONFIRMED)_MUCOLIPIDOSIS_III_ALPHA/BETA,252600|MUCOLIPIDOSIS_II_ALPHA/BETA,252500]
chr12	111893823	111894070	GS140549_01	248	1	3	5.39	0.065	chr12:111893823-111894070		ATXN2		601517_[ATXN2_(CONFIRMED)_SPINOCEREBELLAR_ATAXIA_2,183090|AMYOTROPHIC_LATERAL_SCLEROSIS,SUSCEPTIBILITY_TO,13,183090|PARKINSON_DISEASE,LATE-ONSET,SUSCEPTIBILITY_TO,168600]
chr12	116421975	116422187	GS140549_01	213	1	3	3.83	0.039	chr12:116421975-116422187		MED13L	MED13L	608771_[MED13L_(PROVISIONAL)_TRANSPOSITION_OF_THE_GREAT_ARTERIES,DEXTRO-LOOPED_1,608808|MENTAL_RETARDATION_AND_DISTINCTIVE_FACIAL_FEATURES_WITH_OR_WITHOUT_CARDIAC_DEFECTS,616789]
chr12	121431313	121431519	GS140549_01	207	1	3	3.87	0.026	chr12:121431313-121431519		HNF1A		142410_[HNF1A_(CONFIRMED)_MODY,TYPE_III,600496|DIABETES_MELLITUS,NONINSULIN-DEPENDENT,2,125853|DIABETES_MELLITUS,INSULIN-DEPENDENT,222100|HEPATIC_ADENOMA,SOMATIC,142330|RENAL_CELL_CARCINOMA,144700|DIABETES_MELLITUS,INSULIN-DEPENDENT,20,612520]
chr13	32839577	32839763	GS140549_01	187	1	3	3.97	0.033	chr13:32839577-32839763		FRY		
chr13	77570027	77570272	GS140549_01	246	1	3	3.59	0.013	chr13:77570027-77570272		CLN5		608102_[CLN5_(CONFIRMED)_CEROID_LIPOFUSCINOSIS,NEURONAL,5,256731]
chr14	90450850	90451037	GS140549_01	188	1	3	3.95	0.013	chr14:90450850-90451037		TDP1		607198_[TDP1_(CONFIRMED)_SPINOCEREBELLAR_ATAXIA,AUTOSOMAL_RECESSIVE_WITH_AXONAL_NEUROPATHY,607250]
chr15	42696967	42697163	GS140549_01	197	1	3	3.78	0.020	chr15:42696967-42697163		CAPN3		114240_[CAPN3_(CONFIRMED)_MUSCULAR_DYSTROPHY,LIMB-GIRDLE,TYPE_2A,253600]
chr15	43268905	43269075	GS140549_01	171	1	3	3.84	0.033	chr15:43268905-43269075		UBR1	UBR1	605981_[UBR1_(CONFIRMED)_JOHANSON-BLIZZARD_SYNDROME,243800]
chr15	48797212	48797354	GS140549_01	143	1	3	3.52	0.065	chr15:48797212-48797354		FBN1	FBN1	134797_[FBN1_(CONFIRMED)_MARFAN_SYNDROME,154700|MARFAN_LIPODYSTROPHY_SYNDROME,616914|ECTOPIA_LENTIS,FAMILIAL,129600|MASS_SYNDROME,604308|WEILL-MARCHESANI_SYNDROME_2,DOMINANT,608328|STIFF_SKIN_SYNDROME,184900|ACROMICRIC_DYSPLASIA,102370|GELEOPHYSIC_DYSPLASIA_2,614185]
chr15	51221196	51221375	GS140549_01	180	1	3	3.57	0.013	chr15:51221196-51221375		AP4E1		607244_[AP4E1_(PROVISIONAL)_SPASTIC_PARAPLEGIA_51,AUTOSOMAL_RECESSIVE,613744|STUTTERING,FAMILIAL_PERSISTENT,1,184450]
chr15	76523664	76523749	GS140549_01	86	1	1	-3.62	0.013	chr15:76523664-76523749		ETFA		608053_[ETFA_(CONFIRMED)_GLUTARIC_ACIDEMIA_IIA,231680]
chr16	2155313	2155485	GS140549_01	173	1	3	4.66	0.111	chr16:2155313-2155485	yes	PKD1	PKD1	601313_[PKD1_(CONFIRMED)_POLYCYSTIC_KIDNEY_DISEASE,ADULT_TYPE_I,173900]
chr16	3781767	3786214	GS140549_01	4448	2	3,3	4.25,2.63	0.039,0.026	chr16:3781767-3781948,chr16:3786027-3786214		CREBBP	CREBBP	600140_[CREBBP_(CONFIRMED)_RUBINSTEIN-TAYBI_SYNDROME_1,180849]
chr16	28855261	28855432	GS140549_01	172	1	1	-4.07	0.065	chr16:28855261-28855432		MIR4721,TUFM		602389_[TUFM_(CONFIRMED)_COMBINED_OXIDATIVE_PHOSPHORYLATION_DEFICIENCY_4,610678]
chr16	53671597	53671776	GS140549_01	180	1	3	3.60	0.026	chr16:53671597-53671776		RPGRIP1L		610937_[RPGRIP1L_(CONFIRMED)_JOUBERT_SYNDROME_7,611560|MECKEL_SYNDROME_5,611561|COACH_SYNDROME,216360]
chr16	70298851	70299015	GS140549_01	165	1	3	4.30	0.007	chr16:70298851-70299015		AARS		601065_[AARS_(CONFIRMED)_CHARCOT-MARIE-TOOTH_DISEASE,AXONAL,TYPE_2N,613287|EPILEPTIC_ENCEPHALOPATHY,EARLY_INFANTILE,29,616339]
chr16	81397389	81397558	GS140549_01	170	1	3	4.05	0.065	chr16:81397389-81397558		GAN		605379_[GAN_(CONFIRMED)_GIANT_AXONAL_NEUROPATHY-1,256850]
chr17	7351888	7357849	GS140549_01	5962	2	3,3	2.98,3.96	0.052,0.046	chr17:7351888-7352117,chr17:7357606-7357849		CHRNB1		100710_[CHRNB1_(CONFIRMED)_MYASTHENIC_SYNDROME,CONGENITAL,2A,SLOW-CHANNEL,616313|MYASTHENIC_SYNDROME,CONGENITAL,2C,ASSOCIATED_WITH_ACETYLCHOLINE_RECEPTOR_DEFICIENCY,616314]
chr17	10307637	10307912	GS140549_01	276	1	3	4.44	0.046	chr17:10307637-10307912		MYH8		160741_[MYH8_(CONFIRMED)_CARNEY_COMPLEX_VARIANT,608837|TRISMUS-PSEUDOCAMPTODACTYLY_SYNDROME,158300]
chr17	15163957	15165899	GS140549_01	1943	2	3,3	3.74,2.73	0.105,0.072	chr17:15163957-15164103,chr17:15165736-15165899		PMP22	PMP22	601097_[PMP22_(CONFIRMED)_CHARCOT-MARIE-TOOTH_DISEASE,TYPE_1A,118220|DEJERINE-SOTTAS_DISEASE,145900|NEUROPATHY,RECURRENT,WITH_PRESSURE_PALSIES,162500|CHARCOT-MARIE-TOOTH_DISEASE,TYPE_1E,118300|ROUSSY-LEVY_SYNDROME,180800|NEUROPATHY,INFLAMMATORY_DEMYELINATING,139393]
chr17	40498577	40498741	GS140549_01	165	1	3	4.22	0.013	chr17:40498577-40498741		STAT3		102582_[STAT3_(PROVISIONAL)_HYPER-IGE_RECURRENT_INFECTION_SYNDROME,147060|AUTOIMMUNE_DISEASE,MULTISYSTEM,INFANTILE-ONSET,1,615952]
chr17	48268168	48268295	GS140549_01	128	1	3	3.97	0.052	chr17:48268168-48268295		COL1A1	COL1A1	120150_[COL1A1_(CONFIRMED)_OSTEOGENESIS_IMPERFECTA,TYPE_I,166200|OSTEOGENESIS_IMPERFECTA,TYPE_II,166210|OSTEOGENESIS_IMPERFECTA,TYPE_III,259420|OSTEOGENESIS_IMPERFECTA,TYPE_IV,166220|EHLERS-DANLOS_SYNDROME,CLASSIC,130000|EHLERS-DANLOS_SYNDROME,TYPE_VIIA,130060|CAFFEY_DISEASE,114000|BONE_MINERAL_DENSITY_VARIATION_QTL,OSTEOPOROSIS,166710]
chr17	48649229	48649408	GS140549_01	180	1	3	3.61	0.046	chr17:48649229-48649408		CACNA1G		604065_[CACNA1G_(PROVISIONAL)_SPINOCEREBELLAR_ATAXIA_42,616795]
chr17	57126529	57126764	GS140549_01	236	1	3	3.77	0.033	chr17:57126529-57126764		TRIM37		605073_[TRIM37_(CONFIRMED)_MULIBREY_NANISM,253250]
chr17	62489002	62489148	GS140549_01	147	1	3	3.87	0.046	chr17:62489002-62489148		POLG2		604983_[POLG2_(PROVISIONAL)_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA_WITH_MITOCHONDRIAL_DNA_DELETIONS,AUTOSOMAL_DOMINANT_4,610131]
chr17	76120595	76120872	GS140549_01	278	1	3	3.91	0.039	chr17:76120595-76120872		TMC6		605828_[TMC6_(CONFIRMED)_EPIDERMODYSPLASIA_VERRUCIFORMIS,226400]
chr17	79478919	79479178	GS140549_01	260	1	3	3.66	0.065	chr17:79478919-79479178		ACTG1		102560_[ACTG1_(CONFIRMED)_DEAFNESS,AUTOSOMAL_DOMINANT_20/26,604717|BARAITSER-WINTER_SYNDROME_2,614583]
chr17	80050321	80050475	GS140549_01	155	1	1	-3.97	0.059	chr17:80050321-80050475		FASN		
chr18	7002253	7002394	GS140549_01	142	1	3	4.05	0.039	chr18:7002253-7002394		LAMA1		150320_[LAMA1_(PROVISIONAL)_PORETTI-BOLTSHAUSER_SYNDROME,615960]
chr18	21508579	21508739	GS140549_01	161	1	3	4.05	0.059	chr18:21508579-21508739		LAMA3		600805_[LAMA3_(PROVISIONAL)_EPIDERMOLYSIS_BULLOSA,JUNCTIONAL,HERLITZ_TYPE,226700|EPIDERMOLYSIS_BULLOSA,GENERALIZED_ATROPHIC_BENIGN,226650|LARYNGOONYCHOCUTANEOUS_SYNDROME,245660]
chr19	6719212	6719424	GS140549_01	213	1	3	5.24	0.052	chr19:6719212-6719424		C3	C3	120700_[C3_(CONFIRMED)_C3_DEFICIENCY,613779|HEMOLYTIC_UREMIC_SYNDROME,ATYPICAL,SUSCEPTIBILITY_TO,5,612925|MACULAR_DEGENERATION,AGE-RELATED,9,611378]
chr19	7170538	7170772	GS140549_01	235	1	3	4.64	0.013	chr19:7170538-7170772		INSR		147670_[INSR_(CONFIRMED)_LEPRECHAUNISM,246200|RABSON-MENDENHALL_SYNDROME,262190|DIABETES_MELLITUS,INSULIN-RESISTANT,WITH_ACANTHOSIS_NIGRICANS,610549|HYPERINSULINEMIC_HYPOGLYCEMIA,FAMILIAL,5,609968]
chr19	7709490	7709648	GS140549_01	159	1	3	3.73	0.046	chr19:7709490-7709648		STXBP2		601717_[STXBP2_(PROVISIONAL)_HEMOPHAGOCYTIC_LYMPHOHISTIOCYTOSIS,FAMILIAL,5,613101]
chr19	11143956	11144203	GS140549_01	248	1	3	4.79	0.078	chr19:11143956-11144203		SMARCA4	SMARCA4	603254_[SMARCA4_(PROVISIONAL)_RHABDOID_TUMOR_PREDISPOSITION_SYNDROME_2,613325|COFFIN-SIRIS_SYNDROME_4,614609]
chr19	11170419	11170571	GS140549_01	153	1	3	5.09	0.072	chr19:11170419-11170571		SMARCA4	SMARCA4	603254_[SMARCA4_(PROVISIONAL)_RHABDOID_TUMOR_PREDISPOSITION_SYNDROME_2,613325|COFFIN-SIRIS_SYNDROME_4,614609]
chr19	12772064	12772200	GS140549_01	137	1	3	3.61	0.013	chr19:12772064-12772200		MAN2B1		609458_[MAN2B1_(CONFIRMED)_MANNOSIDOSIS,ALPHA-,TYPES_I_AND_II,248500]
chr19	13446610	13446733	GS140549_01	124	1	3	4.25	0.033	chr19:13446610-13446733		CACNA1A	CACNA1A	601011_[CACNA1A_(CONFIRMED)_MIGRAINE,FAMILIAL_HEMIPLEGIC,1,141500|EPISODIC_ATAXIA,TYPE_2,108500|SPINOCEREBELLAR_ATAXIA_6,183086|MIGRAINE,FAMILIAL_HEMIPLEGIC,1,WITH_PROGRESSIVE_CEREBELLAR_ATAXIA,141500|EPILEPTIC_ENCEPHALOPATHY,EARLY_INFANTILE,42,617106]
chr19	39014545	39014579	GS140549_01	35	1	1	-3.65	0.065	chr19:39014545-39014579		RYR1		180901_[RYR1_(CONFIRMED)_MALIGNANT_HYPERTHERMIA_SUSCEPTIBILITY_1,145600|CENTRAL_CORE_DISEASE,117000|MINICORE_MYOPATHY_WITH_EXTERNAL_OPHTHALMOPLEGIA,255320|NEUROMUSCULAR_DISEASE,CONGENITAL,WITH_UNIFORM_TYPE_1_FIBER,117000|KING-DENBOROUGH_SYNDROME,145600]
chr19	39058403	39058567	GS140549_01	165	1	3	4.12	0.052	chr19:39058403-39058567		RYR1		180901_[RYR1_(CONFIRMED)_MALIGNANT_HYPERTHERMIA_SUSCEPTIBILITY_1,145600|CENTRAL_CORE_DISEASE,117000|MINICORE_MYOPATHY_WITH_EXTERNAL_OPHTHALMOPLEGIA,255320|NEUROMUSCULAR_DISEASE,CONGENITAL,WITH_UNIFORM_TYPE_1_FIBER,117000|KING-DENBOROUGH_SYNDROME,145600]
chr19	47251274	47251355	GS140549_01	82	1	3	3.54	0.033	chr19:47251274-47251355		FKRP		606596_[FKRP_(CONFIRMED)_MUSCULAR_DYSTROPHY-DYSTROGLYCANOPATHY_(CONGENITAL_WITH_BRAIN_AND_EYE_ANOMALIES),TYPE_A,5,613153|MUSCULAR_DYSTROPHY-DYSTROGLYCANOPATHY_(CONGENITAL_WITH_OR_WITHOUT_MENTAL_RETARDATION),TYPE_B,5,606612|MUSCULAR_DYSTROPHY-DYSTROGLYCANOPATHY_(LIMB-GIRDLE),TYPE_C,5,607155]
chr19	54694109	54694311	GS140549_01	203	1	4	4.74	0.059	chr19:54694109-54694311		TSEN34		608754_[TSEN34_(PROVISIONAL)_PONTOCEREBELLAR_HYPOPLASIA_TYPE_2C,612390]
chr20	47601256	47601387	GS140549_01	132	1	3	6.32	0.059	chr20:47601256-47601387		ARFGEF2		605371_[ARFGEF2_(CONFIRMED)_PERIVENTRICULAR_HETEROTOPIA_WITH_MICROCEPHALY,608097]
chr20	62073749	62073894	GS140549_01	146	1	4	3.99	0.046	chr20:62073749-62073894		KCNQ2	KCNQ2	602235_[KCNQ2_(CONFIRMED)_SEIZURES,BENIGN_NEONATAL,1,121200|MYOKYMIA,121200|EPILEPTIC_ENCEPHALOPATHY,EARLY_INFANTILE,7,613720]
chr20	62560655	62560888	GS140549_01	234	1	3	3.94	0.020	chr20:62560655-62560888		DNAJC5		611203_[DNAJC5_(PROVISIONAL)_CEROID_LIPOFUSCINOSIS,NEURONAL,4,PARRY_TYPE,162350]
chr21	33031925	33032164	GS140549_01	240	1	4	5.05	0.183	chr21:33031925-33032164		SOD1		147450_[SOD1_(CONFIRMED)_AMYOTROPHIC_LATERAL_SCLEROSIS_1,105400]
chr21	44485487	44485815	GS140549_01	329	2	1,1	-3.30,-4.50	0.052,0.046	chr21:44485487-44485641,chr21:44485716-44485815		CBS		613381_[CBS_(CONFIRMED)_HOMOCYSTINURIA,B6-RESPONSIVE_AND_NONRESPONSIVE_TYPES,236200|THROMBOSIS,HYPERHOMOCYSTEINEMIC,236200]
chr21	47418801	47419616	GS140549_01	816	3	1,1,1	-2.42,-2.30,-3.55	0.039,0.039,0.039	chr21:47418801-47418883,chr21:47419057-47419142,chr21:47419561-47419616		COL6A1	COL6A1	120220_[COL6A1_(CONFIRMED)_BETHLEM_MYOPATHY_1,158810|ULLRICH_CONGENITAL_MUSCULAR_DYSTROPHY_1,254090]
chr22	17578677	17578843	GS140549_01	167	1	3	4.94	0.078	chr22:17578677-17578843		IL17RA		605461_[IL17RA_(PROVISIONAL)_IMMUNODEFICIENCY_51,613953]
chr22	42522491	42524362	GS140549_01	1872	5	1,1,1,1,1	-2.05,-2.65,-5.84,-3.75,-3.93	0.105,0.118,0.137,0.131,0.131	chr22:42522491-42522764,chr22:42522843-42523004,chr22:42523439-42523646,chr22:42523834-42523995,chr22:42524166-42524362	yes	CYP2D6,NDUFA6-AS1	CYP2D6	124030_[CYP2D6_(CONFIRMED)_DEBRISOQUINE_SENSITIVITY,608902|CODEINE_SENSITIVITY,608902]
chrX	10180497	10180703	GS140549_01	207	1	3	4.95	0.065	chrX:10180497-10180703		CLCN4		302910_[CLCN4_(PROVISIONAL)_MENTAL_RETARDATION,X-LINKED_49/15,300114]
chrX	13779194	13779340	GS140549_01	147	1	3	3.60	0.026	chrX:13779194-13779340		OFD1	OFD1	300170_[OFD1_(CONFIRMED)_OROFACIODIGITAL_SYNDROME_I,311200|SIMPSON-GOLABI-BEHMEL_SYNDROME,TYPE_2,300209|JOUBERT_SYNDROME_10,300804|RETINITIS_PIGMENTOSA_23,300424]
chrX	21624887	21625007	GS140549_01	121	1	4	5.82	0.085	chrX:21624887-21625007		CNKSR2		
chrX	32613864	32614003	GS140549_01	140	1	3	3.81	0.059	chrX:32613864-32614003		DMD	DMD	300377_[DMD_(CONFIRMED)_DUCHENNE_MUSCULAR_DYSTROPHY,310200|BECKER_MUSCULAR_DYSTROPHY,300376|CARDIOMYOPATHY,DILATED,3B,302045]
chrX	32715977	32716125	GS140549_01	149	1	3	4.37	0.033	chrX:32715977-32716125		DMD	DMD	300377_[DMD_(CONFIRMED)_DUCHENNE_MUSCULAR_DYSTROPHY,310200|BECKER_MUSCULAR_DYSTROPHY,300376|CARDIOMYOPATHY,DILATED,3B,302045]
chrX	38533465	38533580	GS140549_01	116	1	3	3.51	0.039	chrX:38533465-38533580		TSPAN7	TSPAN7	300096_[TSPAN7_(CONFIRMED)_MENTAL_RETARDATION,X-LINKED_58,300210]
chrX	47082941	47083168	GS140549_01	228	1	3	4.27	0.085	chrX:47082941-47083168		CDK16		
chrX	49071792	49072013	GS140549_01	222	1	3	4.89	0.065	chrX:49071792-49072013		CACNA1F		300110_[CACNA1F_(CONFIRMED)_NIGHT_BLINDNESS,CONGENITAL_STATIONARY_(INCOMPLETE),2A,X-LINKED,300071|CONE-ROD_DYSTROPHY,X-LINKED,3,300476|ALAND_ISLAND_EYE_DISEASE,300600]
chrX	49079378	49081458	GS140549_01	2081	2	3,3	3.59,3.01	0.033,0.059	chrX:49079378-49079605,chrX:49081213-49081458		CACNA1F		300110_[CACNA1F_(CONFIRMED)_NIGHT_BLINDNESS,CONGENITAL_STATIONARY_(INCOMPLETE),2A,X-LINKED,300071|CONE-ROD_DYSTROPHY,X-LINKED,3,300476|ALAND_ISLAND_EYE_DISEASE,300600]
chrX	68835901	68836558	GS140549_01	658	1	1	-3.88	0.046	chrX:68835901-68836558		EDA	EDA	300451_[EDA_(CONFIRMED)_ECTODERMAL_DYSPLASIA_1,HYPOHIDROTIC,X-LINKED,305100|TOOTH_AGENESIS,SELECTIVE,X-LINKED_1,313500]
chrX	76854870	76855059	GS140549_01	190	1	3	3.73	0.052	chrX:76854870-76855059		ATRX	ATRX	300032_[ATRX_(CONFIRMED)_ALPHA-THALASSEMIA/MENTAL_RETARDATION_SYNDROME,301040|ALPHA-THALASSEMIA_MYELODYSPLASIA_SYNDROME,SOMATIC,300448|MENTAL_RETARDATION-HYPOTONIC_FACIES_SYNDROME,X-LINKED,309580]
chrX	77112844	77113004	GS140549_01	161	1	3	4.64	0.052	chrX:77112844-77113004		MAGT1	MAGT1	300715_[MAGT1_(PROVISIONAL)_IMMUNODEFICIENCY,X-LINKED,WITH_MAGNESIUM_DEFECT,EPSTEIN-BARR_VIRUS_INFECTION_AND_NEOPLASIA,300853]
chrX	77227108	77227268	GS140549_01	161	1	3	3.54	0.039	chrX:77227108-77227268		ATP7A	ATP7A	300011_[ATP7A_(CONFIRMED)_MENKES_DISEASE,309400|OCCIPITAL_HORN_SYNDROME,304150|SPINAL_MUSCULAR_ATROPHY,DISTAL,X-LINKED_3,300489]
chrX	79937486	79937603	GS140549_01	118	1	3	3.80	0.072	chrX:79937486-79937603		BRWD3	BRWD3	300553_[BRWD3_(PROVISIONAL)_MENTAL_RETARDATION,X-LINKED_93,300659]
chrX	106890826	106891005	GS140549_01	180	1	3	3.95	0.026	chrX:106890826-106891005		PRPS1	PRPS1	311850_[PRPS1_(CONFIRMED)_GOUT,PRPS-RELATED,300661|PHOSPHORIBOSYLPYROPHOSPHATE_SYNTHETASE_SUPERACTIVITY,300661|CHARCOT-MARIE-TOOTH_DISEASE,X-LINKED_RECESSIVE,5,311070|ARTS_SYNDROME,301835|DEAFNESS,X-LINKED_1,304500]
chrX	122613904	122614038	GS140549_01	135	1	3	3.82	0.039	chrX:122613904-122614038		GRIA3	GRIA3	305915_[GRIA3_(CONFIRMED)_MENTAL_RETARDATION,X-LINKED_94,300699]
chrX	153583183	153583450	GS140549_01	268	1	3	4.79	0.046	chrX:153583183-153583450		FLNA	FLNA	300017_[FLNA_(CONFIRMED)_HETEROTOPIA,PERIVENTRICULAR,300049|OTOPALATODIGITAL_SYNDROME,TYPE_I,311300|OTOPALATODIGITAL_SYNDROME,TYPE_II,304120|INTESTINAL_PSEUDOOBSTRUCTION,NEURONAL,300048|MELNICK-NEEDLES_SYNDROME,309350|FRONTOMETAPHYSEAL_DYSPLASIA_1,305620|FG_SYNDROME_2,300321|CARDIAC_VALVULAR_DYSPLASIA,X-LINKED,314400|TERMINAL_OSSEOUS_DYSPLASIA,300244|CONGENITAL_SHORT_BOWEL_SYNDROME,300048]
